Dimerization inhibitors of HIV-1 protease

Biological Chemistry

Volumn 383, Issue 9, 2002, Pages 1321-1324

  Boggetto, Nicole ^a   Reboud Ravaux, Michèle ^a  

^a INSTITUT JACQUES MONOD   (France)

Author keywords

AIDS; Dimerization inhibitors; HIV 1 protease; Interface peptides; Lipopeptides; Molecular hairpins

Indexed keywords

LIPOPEPTIDE DERIVATIVE; PROTEIN DERIVATIVE; PROTEINASE INHIBITOR; UNCLASSIFIED DRUG; VIRUS ENZYME; PROTEINASE;

AMINO ACID SEQUENCE; AMINO TERMINAL SEQUENCE; ARTICLE; BETA SHEET; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; CROSS LINKING; DIMERIZATION; DRUG DESIGN; DRUG RESISTANCE; DRUG STRUCTURE; DRUG TARGETING; ENZYME STRUCTURE; HUMAN IMMUNODEFICIENCY VIRUS 1; NONHUMAN; PRIORITY JOURNAL; CHEMICAL STRUCTURE; HUMAN; METABOLISM; MOLECULAR MIMICRY; REVIEW;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

DIMERIZATION; DRUG DESIGN; HIV PROTEASE; HIV PROTEASE INHIBITORS; HUMANS; MODELS, MOLECULAR; MOLECULAR MIMICRY;

EID: 0036753937     PISSN: 14316730     EISSN: None     Source Type: Journal    
DOI: 10.1515/BC.2002.150     Document Type: Article

References (28)

1. Babé, L. M., Rose J., and Craik, C. S. (1992). Synthetic 'interface' peptides alter dimeric assembly of the HIV 1 and 2 proteases. Protein Sci. 1, 1244-1253.
2. Bouras, A., Boggetto, N., Benatalah, Z., de Rosny, E., Sicsic, S., and Reboud-Ravaux, M. (1999). Design, synthesis, and evaluation of conformationally constrained tongs, new inhibitors of HIV-1 protease dimerization. J. Med. Chem. 42, 957-962.
3. Caflish, A., Schramm, H. J., and Karplus, M. (2000). Design of dimerization inhibitors of HIV-1 aspartic proteinase: a computer-based combinational approach. J. Comp. Aid. Mol. Des. 14, 161-179.
4. Carr, A., Samaras, K., Chisholm, D. J., and Cooper, D. A. (1998). Pathogenesis of HIV-1-protease inhibitor-associated peripheral lipodystrophy, hyperlipidaemia, and insulin resistance. Lancet 352, 1881-1883.
5. de Clercq, E. (1995). Toward improved anti-HIV chemotherapy: therapeutic strategies for intervention with HIV infections. J. Med. Chem. 38, 2491-2517.
6. Darke P. L., Jordan, S. P., Hall, D. L., Zugay, J. A., Shafer, J. A., and Kuo, L. C. (1994). Dissociation and association of the HIV-1 protease dimer subunits: equilibria and rates. Biochemistry 33, 98-105.
7. Dumond, J., Boggetto, N., Reboud-Ravaux, M., Schramm, H. J., Schramm, W., and Dölling, R. (2001). Thyroxine-containing lipopeptides as interface targeting inhibitors of HIV-1 protease: a pathway to circumvent protease inhibitor resistance (P195). Second General Meeting of the International Proteolysis Society associated with the International Conference on Protease Inhibitors, Freising, Germany.
8. Fan, X., Flentke, G. R., and Rich, D. H. (1998). Inhibition of HIV-1 protease by a subunit of didemnaketal A. J. Am. Chem. Soc. 120, 8893-8894.
9. Franciskovich, J., Houseman, K., Mueller, R., and Chmielewski, J. (1993). A systematic evaluation of the inhibition of HIV-1 protease by its C- and N-terminal peptides. Bioorg. Med. Chem. Lett. 3, 765-768.
10. Ishima, R., Ghirlando, R., Tozser, J., Gronenborn, A. M., Torchia, D. A., and Louis, J. M. (2001). Folded monomer of HIV-1 protease. J. Biol. Chem. 276, 49110-49116.
11. Kräusslich, H. (1991). Human immunodeficiency virus proteinase dimer as component of the viral polyprotein prevents particle assembly and viral infectivity. Proc. Natl. Acad. Sci. 88, 1580-1584.
12. Gustchina, A., and Weber, I. T. (1991). Comparative analysis of the sequences and structures of HIV-1 and HIV-2 proteases. Proteins 10, 325-339.
13. Park, S.-H., and Raines, R. T. (2000). Genetic selection for the dissociative inhibitors of designated protein-protein interactions. Nature Biotechnol. 18, 847-851.
14. Petry, H., Ast, O., de Rosny, E., Lieder, K., Jentsch, K. D., Hunsmann, G., Goldmann, C., Lüke, W., Büttner, J., Reboud-Ravaux, M., Schramm, W., and Schramm, H. J. (1999). Inhibition of HIV-1 replication by peptidic protease inhibitors. In: HIV-infekt, N. H. Brockmeyer, R. Brodt, K. Hoffmann, G. Reimann, M. Stücker and P. Altmeyer, eds. (Berlin, Germany: Springer), pp. 63-67.
15. Schramm, H. J., Nakashima, H., Schramm, W., Wakayama, H., and Yamamoto, N. (1991). HIV-1 reproduction is inhibited by peptides derived from the N- and C-termini of HIV-1 protease. Biochem. Biophys. Res. Commun. 179, 847-851.
16. Schramm, H. J., Boetzel, J., Buttner, J., Fritsche, E., Gohring, W., Jaeger, E., Konig, S., Thumfart, O., Wenger, T., Nagel, N. E., and Schramm, W. (1996). The inhibition of human immunodeficiency virus proteases by 'interface peptides'. Antiviral Res. 30, 55-70.
17. Schramm, H. J., de Rosny, E., Reboud-Ravaux, M., Buttner, J., Dick, A., and Schramm, W. (1999). Lipopeptides as dimerization inhibitors of HIV-1 protease. Biol. Chem. 380, 593-596.
18. Shultz, M. D., Bowman, M. J., Ham, Y.-W., Zhao, X., Tora, G., and Chmielewski, J. (2000). Small-molecules inhibitors of HIV-1 protease dimerization derived from cross-linked interfacial peptides. Angew. Chem. Int. Ed. 39, 2710-2713.
19. Shultz, M. D., and Chmielewski, J. (1999). Probing the role of interfacial residues in a dimerization inhibitor of HIV-1 protease. Bioorg. Med. Chem. Lett. 9, 2431-2436.
20. Song, M., Rajesh, S., Hayashi, Y., and Kiso, Y. (2001). Design and synthesis of new inhibitors of HIV-1 protease dimerization with conformationally constrained templates. Bioorg. Med. Chem. Lett. 11, 2465-2468.
21. Todd, M. J., Semo, N., and Freire, E. (1998). The structural stability of the HIV-1 protease. J. Mol. Biol. 283, 475-488.
22. Todd, S., Anderson, C. G., Jolly, D. J., and Craik, C. S. (2000). HIV protease as a target for retrovirus vector-mediated gene therapy. Biochim. Biophys. Acta 1477, 168-188.
23. Uhlíková T, Konvalinka, J, Pichová, I, Souek, M, Kräusslich, H. G, and Vondráek, J. (1996). A modular approach to HIV-1 proteinase inhibitor design. Biochem. Biophys. Res. Commun. 222, 38-43.
24. Wlodawer, A., Miller, M., Jaskolski, M., Sathyanarayana, B. K., Baldwin, E., Weber, I. T., Selk, L. M., Clawson, L., Schneider, J., and Kent, S. B. (1989). Conserved folding in retroviral proteases: crystal structure of a synthetic HIV-1 protease. Science 245, 616-621.
25. Zhang, Z. Y., Poorman, R. A., Maggiora, L. L., Heinrikson, R. L., and Kezdy, F. J. (1991). Dissociative inhibition of dimeric enzymes. Kinetic characterization of the inhibition of HIV-1 protease by its COOH-terminal tetrapeptide. J. Biol. Chem. 266, 15591-15594.
26. Zutshi, R., and Chmielewski, J. (2000). Targeting the dimerization interface for irreversible inhibition of HIV-1 protease. Bioorg. Med. Chem. Lett. 10, 1901-1903.
27. Zutshi, R., Franciskovich, J., Shultz, M., Schweitzer B., Bishop, P. Wilson, M., and Chmielewski, J. (1997). Targeting the dimerization interface of HIV-1 protease: inhibition with cross-linked interfacial peptides. J. Am. Chem. Soc. 199, 4841-4845.
28. Zutshi, R., Brickner, M., and Chmielewski J. (1998). Inhibiting the assembly of protein-protein interfaces. Curr. Opin. Chem. Biol. 2, 62-66.